Quantinuum (NASDAQ:QNT – Get Free Report) was upgraded by analysts at Jefferies Financial Group to a “strong-buy” rating in a research report issued to clients and investors on Monday,Zacks.com reports.
Several other research analysts have also issued reports on QNT. Evercore started coverage on shares of Quantinuum in a research note on Monday. They issued an “outperform” rating and a $98.00 target price on the stock. Sanford C. Bernstein began coverage on shares of Quantinuum in a report on Monday. They issued an “outperform” rating and a $94.00 price objective on the stock. Rosenblatt Securities assumed coverage on shares of Quantinuum in a report on Monday. They set a “buy” rating and a $155.00 target price for the company. Mizuho assumed coverage on Quantinuum in a research note on Monday. They issued an “outperform” rating and a $90.00 price target on the stock. Finally, Needham & Company LLC began coverage on Quantinuum in a research report on Monday. They issued a “buy” rating and a $100.00 price target on the stock. Three equities research analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, Quantinuum currently has an average rating of “Buy” and a consensus target price of $98.75.
View Our Latest Analysis on Quantinuum
Quantinuum Stock Performance
Insider Activity
In related news, insider Kevin Scott Dehoff purchased 15,000 shares of the business’s stock in a transaction on Friday, June 5th. The shares were purchased at an average price of $60.00 per share, with a total value of $900,000.00. Following the completion of the purchase, the insider owned 126,460 shares in the company, valued at $7,587,600. This represents a 13.46% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Kenneth D. Denman acquired 14,000 shares of the stock in a transaction dated Friday, June 5th. The shares were bought at an average cost of $60.00 per share, with a total value of $840,000.00. Following the transaction, the director directly owned 19,833 shares of the company’s stock, valued at $1,189,980. This represents a 240.01% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders acquired 411,032 shares of company stock worth $24,661,920.
Quantinuum News Summary
Here are the key news stories impacting Quantinuum this week:
- Positive Sentiment: Multiple firms initiated coverage on Quantinuum with bullish calls, including JPMorgan, Rosenblatt, Craig Hallum, Bank of America, Needham, Mizuho, and Sanford C. Bernstein, with several price targets implying meaningful upside. Analyst coverage and price targets
- Positive Sentiment: Rosenblatt was the most bullish, assigning a buy rating and a $155 target, signaling strong confidence in Quantinuum’s long-term growth potential. Rosenblatt coverage
- Positive Sentiment: Congressional trading activity also drew attention after Rep. Cleo Fields reportedly made a new quantum-related bet, adding to investor interest in the sector. Congressman Who Buys Magnificent Seven Stocks With Size Made New Quantum Bet
- Neutral Sentiment: Morgan Stanley initiated coverage with an equal weight rating and a $78 target, which is more cautious than peers but still above the recent trading level. Morgan Stanley coverage
- Negative Sentiment: Despite the bullish analyst wave, the stock has been falling, suggesting investors may be taking profits or reacting to valuation concerns after the sharp run-up in interest around quantum computing. Quantinuum stock falls: why is Wall Street bullish on the stock?
Quantinuum Company Profile
Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.
The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.
Further Reading
- Five stocks we like better than Quantinuum
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.
